NeuImmune, Inc.

NeuImmune, Inc. is an early-stage biotechnology company founded by leading scientists in the field of glyco- and cell-engineering from the University of Maryland, University of California, San Diego, and the Technical University of Denmark.  Our vision, through the engineering of precision biologics, is to position NeuImmune as the leading glycoprotein therapeutics company focused on addressing unmet rare diseases.